QQQ   353.15 (+1.24%)
AAPL   180.57 (+1.55%)
MSFT   325.26 (+0.58%)
META   264.58 (+0.37%)
GOOGL   122.14 (-0.29%)
AMZN   124.25 (+2.49%)
TSLA   234.86 (+4.58%)
NVDA   385.10 (+2.76%)
NIO   7.79 (+0.39%)
BABA   86.14 (+1.01%)
AMD   121.05 (+2.73%)
T   16.07 (-0.25%)
F   13.58 (-0.07%)
MU   65.32 (-2.59%)
CGC   0.69 (-4.14%)
GE   106.06 (-0.02%)
DIS   92.53 (+0.01%)
AMC   4.68 (-1.06%)
PFE   39.09 (+0.51%)
PYPL   64.24 (+0.31%)
NFLX   409.37 (+2.40%)
QQQ   353.15 (+1.24%)
AAPL   180.57 (+1.55%)
MSFT   325.26 (+0.58%)
META   264.58 (+0.37%)
GOOGL   122.14 (-0.29%)
AMZN   124.25 (+2.49%)
TSLA   234.86 (+4.58%)
NVDA   385.10 (+2.76%)
NIO   7.79 (+0.39%)
BABA   86.14 (+1.01%)
AMD   121.05 (+2.73%)
T   16.07 (-0.25%)
F   13.58 (-0.07%)
MU   65.32 (-2.59%)
CGC   0.69 (-4.14%)
GE   106.06 (-0.02%)
DIS   92.53 (+0.01%)
AMC   4.68 (-1.06%)
PFE   39.09 (+0.51%)
PYPL   64.24 (+0.31%)
NFLX   409.37 (+2.40%)
QQQ   353.15 (+1.24%)
AAPL   180.57 (+1.55%)
MSFT   325.26 (+0.58%)
META   264.58 (+0.37%)
GOOGL   122.14 (-0.29%)
AMZN   124.25 (+2.49%)
TSLA   234.86 (+4.58%)
NVDA   385.10 (+2.76%)
NIO   7.79 (+0.39%)
BABA   86.14 (+1.01%)
AMD   121.05 (+2.73%)
T   16.07 (-0.25%)
F   13.58 (-0.07%)
MU   65.32 (-2.59%)
CGC   0.69 (-4.14%)
GE   106.06 (-0.02%)
DIS   92.53 (+0.01%)
AMC   4.68 (-1.06%)
PFE   39.09 (+0.51%)
PYPL   64.24 (+0.31%)
NFLX   409.37 (+2.40%)
QQQ   353.15 (+1.24%)
AAPL   180.57 (+1.55%)
MSFT   325.26 (+0.58%)
META   264.58 (+0.37%)
GOOGL   122.14 (-0.29%)
AMZN   124.25 (+2.49%)
TSLA   234.86 (+4.58%)
NVDA   385.10 (+2.76%)
NIO   7.79 (+0.39%)
BABA   86.14 (+1.01%)
AMD   121.05 (+2.73%)
T   16.07 (-0.25%)
F   13.58 (-0.07%)
MU   65.32 (-2.59%)
CGC   0.69 (-4.14%)
GE   106.06 (-0.02%)
DIS   92.53 (+0.01%)
AMC   4.68 (-1.06%)
PFE   39.09 (+0.51%)
PYPL   64.24 (+0.31%)
NFLX   409.37 (+2.40%)
NASDAQ:ASRT

Assertio (ASRT) Stock Forecast, Price & News

$6.02
-0.19 (-3.06%)
(As of 06/8/2023 ET)
Compare
Today's Range
$6.01
$6.30
50-Day Range
$5.00
$7.66
52-Week Range
$2.07
$8.01
Volume
1.20 million shs
Average Volume
2.00 million shs
Market Capitalization
$335.31 million
P/E Ratio
3.99
Dividend Yield
N/A
Price Target
$9.50

Assertio MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
57.8% Upside
$9.50 Price Target
Short Interest
Bearish
17.79% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
Selling Shares
$910,646 Sold Last Quarter
Proj. Earnings Growth
83.33%
From $0.36 to $0.66 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.35 out of 5 stars

Medical Sector

192nd out of 986 stocks

Pharmaceutical Preparations Industry

84th out of 475 stocks


ASRT stock logo

About Assertio (NASDAQ:ASRT) Stock

Assertio Holdings, Inc., a commercial pharmaceutical company, provides medicines in the areas of neurology, rheumatology, and pain and inflammation. Its pharmaceutical products include INDOCIN, an oral and suppository solution for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing spondylitis and osteoarthritis; and acute painful shoulder and gouty arthritis. It also provides Sympazan, a benzodiazepine for the adjunctive treatment of seizures related with lennox-gastaut syndrome in patients aged two years of age or older; CAMBIA, a non steroidal anti inflammatory drug (NSAID) for the treatment of migraine pain, nausea, photophobia, and phonophobia; Zipsor, a NSAID for relief of mild to moderate pain in adults; SPRIX, a NSAID for the short term management of moderate to moderately severe pain that requires analgesia at the opioid level; and Otrexup, a single-dose auto-injector containing a prescription medicine and methotrexate that is used to treat patients with severe, active rheumatoid arthritis, and active polyarticular juvenile idiopathic arthritis, as well as treat adult with severe, recalcitrant, and disabling psoriasis. The company was formerly known as Assertio Therapeutics, Inc. and changed its name to Assertio Holdings, Inc. in May 2020. Assertio Holdings, Inc. was incorporated in 1995 and is headquartered in Lake Forest, Illinois.

Receive ASRT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Assertio and its competitors with MarketBeat's FREE daily newsletter.

ASRT Stock News Headlines

"Chilling War Games Show US Forces Crushed" – FOX NEWS
=== BREAKING === "Chilling War Games Show US Forces Crushed" - FOX NEWS After losing to China in repeated war games, U.S. military to spend billions on new "living missile" for armed forces. Investors stand to reap 35,960% on shares of small defense contractor that makes powerful new weapon. Get the name of the stock here >>>
Assertio (NASDAQ:ASRT) Downgraded by StockNews.com to Hold
U.S. Loses to China in Shocking WAR GAMES
=== BREAKING === U.S. Loses to China in Shocking WAR GAMES Pentagon says new "living missile" key to winning a future conflict. Investors stand to reap 35,960% on shares of the small defense contractor that makes powerful new weapon. Get the name of the stock here >>>
Recap: Assertio Holdings Q1 Earnings
Assertio: Q1 Earnings Snapshot
Assertio (NASDAQ: ASRT)
See More Headlines

ASRT Price History

ASRT Company Calendar

Last Earnings
5/09/2023
Today
6/08/2023
Next Earnings (Estimated)
8/14/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:ASRT
Employees
30
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$9.50
High Stock Price Forecast
$10.00
Low Stock Price Forecast
$9.00
Forecasted Upside/Downside
+53.5%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
3 Analysts

Profitability

Net Income
$109.63 million
Pretax Margin
9.74%

Debt

Sales & Book Value

Annual Sales
$156.23 million
Cash Flow
$3.00 per share
Book Value
$4.67 per share

Miscellaneous

Free Float
51,300,000
Market Cap
$344.78 million
Optionable
Optionable
Beta
1.39

Key Executives

  • Mr. Daniel A. PeisertMr. Daniel A. Peisert (Age 48)
    Pres, CEO & Director
    Comp: $2.18M
  • Mr. Paul SchwichtenbergMr. Paul Schwichtenberg (Age 52)
    Sr. VP & CFO
    Comp: $780.88k
  • Mr. Ajay PatelMr. Ajay Patel (Age 39)
    Sr. VP & Chief Accounting Officer
    Comp: $742.01k
  • Mr. Bill Iskos
    Sr. VP of Operations
  • Mr. Sam Schlessinger
    Sr. VP & Gen. Counsel
  • Mr. Jeff Christensen
    Sr. VP of Commercial
  • Dr. Howard J. Franklin M.B.A.
    M.D., Sr. VP of Medical













ASRT Stock - Frequently Asked Questions

Should I buy or sell Assertio stock right now?

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Assertio in the last year. There are currently 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" ASRT shares.
View ASRT analyst ratings
or view top-rated stocks.

What is Assertio's stock price forecast for 2023?

3 brokers have issued 12 month target prices for Assertio's stock. Their ASRT share price forecasts range from $9.00 to $10.00. On average, they predict the company's share price to reach $9.50 in the next year. This suggests a possible upside of 53.5% from the stock's current price.
View analysts price targets for ASRT
or view top-rated stocks among Wall Street analysts.

How have ASRT shares performed in 2023?

Assertio's stock was trading at $4.30 at the start of the year. Since then, ASRT shares have increased by 44.0% and is now trading at $6.19.
View the best growth stocks for 2023 here
.

When is Assertio's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, August 14th 2023.
View our ASRT earnings forecast
.

How were Assertio's earnings last quarter?

Assertio Holdings, Inc. (NASDAQ:ASRT) released its quarterly earnings results on Tuesday, May, 9th. The company reported ($0.07) earnings per share for the quarter, missing analysts' consensus estimates of $0.13 by $0.20. The business earned $42.47 million during the quarter, compared to analysts' expectations of $37.78 million. Assertio had a trailing twelve-month return on equity of 52.50% and a net margin of 59.86%.

What ETFs hold Assertio's stock?

ETFs with the largest weight of Assertio (NASDAQ:ASRT) stock in their portfolio include Hartford Multifactor Small Cap ETF (ROSC).Barrons 400 ETF (BFOR).

What other stocks do shareholders of Assertio own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Assertio investors own include Sorrento Therapeutics (SRNE), Actinium Pharmaceuticals (ATNM), T2 Biosystems (TTOO), VBI Vaccines (VBIV), InterDigital (IDCC), Trevena (TRVN), Ampio Pharmaceuticals (AMPE), Bionano Genomics (BNGO), Cerecor (CERC) and OPKO Health (OPK).

What is Assertio's stock symbol?

Assertio trades on the NASDAQ under the ticker symbol "ASRT."

Who are Assertio's major shareholders?

Assertio's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Renaissance Technologies LLC (3.62%), Acadian Asset Management LLC (2.07%), BlackRock Inc. (1.73%), American Century Companies Inc. (1.16%), Two Sigma Investments LP (1.16%) and Arrowstreet Capital Limited Partnership (1.07%). Insiders that own company stock include Ajay Patel, Daniel A Peisert, Group LP Cr, Heather L Mason, James L Tyree and Paul Schwichtenberg.
View institutional ownership trends
.

How do I buy shares of Assertio?

Shares of ASRT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Assertio's stock price today?

One share of ASRT stock can currently be purchased for approximately $6.19.

How much money does Assertio make?

Assertio (NASDAQ:ASRT) has a market capitalization of $344.78 million and generates $156.23 million in revenue each year. The company earns $109.63 million in net income (profit) each year or $1.51 on an earnings per share basis.

How can I contact Assertio?

Assertio's mailing address is 100 South Saunders Road Suite 300, Lake Forest IL, 60045. The official website for the company is www.assertiotx.com. The company can be reached via phone at (224) 419-7106, via email at investor@assertiotx.com, or via fax at 510-744-8001.

This page (NASDAQ:ASRT) was last updated on 6/8/2023 by MarketBeat.com Staff

My Account -